ACST - Acasti Pharma Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5162.01M
Enterprise Value 3150.2M
Trailing P/E N/A
Forward P/E 1-5.46
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 1.48
52-Week Change 3264.58%
S&P500 52-Week Change 3-0.33%
52 Week High 32.9500
52 Week Low 30.4400
50-Day Moving Average 31.8844
200-Day Moving Average 31.1848

Share Statistics

Avg Vol (3 month) 32.03M
Avg Vol (10 day) 32.13M
Shares Outstanding 5N/A
Float 65.7M
% Held by Insiders 113.28%
% Held by Institutions 14.02%
Shares Short (Jul 31, 2019) 42.19M
Short Ratio (Jul 31, 2019) 40.64
Short % of Float (Jul 31, 2019) 42.81%
Short % of Shares Outstanding (Jul 31, 2019) 42.77%
Shares Short (prior month Jun 28, 2019) 4888.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Oct 15, 2015

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-85.32%
Return on Equity (ttm)-1,006.68%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-1.2240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)52.34
Current Ratio (mrq)1.61
Book Value Per Share (mrq)-0.30

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A